CARA O'BRIEN: Open Payments
NPI 1992414437 · ORLAND PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 33 payments from 19 companies in 2025. Trend: 2023 $2,189 · 2024 $1,607 · 2025 $900
Food & beverage: $800Long term medical supply or device loan: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $213 |
| JAZZ PHARMACEUTICALS INC. | 2 | $108 |
| AstraZeneca Pharmaceuticals LP | 4 | $87 |
| PFIZER INC. | 3 | $57 |
| TerSera Therapeutics LLC | 2 | $54 |
| Celgene Corporation | 2 | $45 |
| BeiGene USA, Inc. | 1 | $38 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| Deciphera Pharmaceuticals Inc. | 1 | $32 |
| Aveo Pharmaceuticals, Inc. | 1 | $32 |
Products named: KISQALI, ZIIHERA, Enhertu, BRUKINSA, QINLOCK, FOTIVDA, SCEMBLIX, Stimufend.
Industry payments across IL — which companies pay providers there.
